Hematology-Oncology Clinics of North America

Article	Citations
Epidemiology of Melanoma	47
The Clinical Management of Clonal Hematopoiesis	42
Molecular Pathogenesis of Mantle Cell Lymphoma	41
Biology of Melanoma	41
Screening for Colorectal Cancer	34
Factor XI Deficiency	33
Diagnosis and Staging of Bladder Cancer	31
The Epidemiology of Bladder Cancer	28
Epidemiology of Follicular Lymphoma	22
Nasopharyngeal Carcinoma and Its Association with Epstein-Barr Virus	22
Lip and Oral Cavity Squamous Cell Carcinoma	20
Blastoid Mantle Cell Lymphoma	19
Immunotherapies Targeting CD123 for Blastic Plasmacytoid Dendritic Cell Neoplasm	19
Overview of Myeloproliferative Neoplasms	18
Current Role and Emerging Evidence for Bruton Tyrosine Kinase Inhibitors in the Treatment of Mantle Cell Lymphoma	17
CD123 as a Therapeutic Target Against Malignant Stem Cells	17
Genetic Predisposition to Myelodysplastic Syndrome in Clinical Practice	16
Secondary Acute Myeloid Leukemia	16
Disorders of Fibrinogen and Fibrinolysis	16
Luspatercept in Myelodysplastic Syndromes	15
Epidemiology of the Philadelphia Chromosome-Negative Classical Myeloproliferative Neoplasms	14
Von Willebrand Disease	14
Hereditary Colorectal Cancer	14
Novel Therapies for Blastic Plasmacytoid Dendritic Cell Neoplasm	14
The Epidemiology of Central Nervous System Tumors	14

Blastic Plasmacytoid Dendritic Cell Neoplasm in Children	14
Genetics of Myeloproliferative Neoplasms	13
Targeting TP53 Mutations in Myelodysplastic Syndromes	13
Blastic Plasmacytoid Dendritic Cell Neoplasm	13
Colorectal Cancer in Younger Adults	13
Acquired von Willebrand Syndrome	13
Molecular Features of Blastic Plasmacytoid Dendritic Cell Neoplasm	12
Hematopoietic Cell Transplant for Blastic Plasmacytoid Dendritic Cell Neoplasm	12
Rare Coagulation Factor Deficiencies (Factors VII, X, V, and II)	12
The Role of Megakaryocytes in Myelofibrosis	12
Tagraxofusp for Blastic Plasmacytoid Dendritic Cell Neoplasm	12
Current Therapy and Emerging Intravesical Agents to Treat Non–Muscle Invasive Bladder Cancer	12
Acquired Hemophilia A	11
Cellular Therapy and Cytokine Treatments for Melanoma	11
Prospects for Venetoclax in Myelodysplastic Syndromes	11
The Microenvironment in Myeloproliferative Neoplasms	11
Racial and Ethnic Disparities in Colorectal Cancer Screening and Outcomes	11
Current Clinical Investigations in Myelofibrosis	11
Gene Therapy for Hemoglobinopathies	10
Pancreatic Adenocarcinoma	10
Central Nervous System Metastases	10
Primary Central Nervous System Lymphomas	10
Impact of Diet and Exercise on Colorectal Cancer	10
Targeting Aberrant Splicing in Myelodysplastic Syndromes	10
Managing Recurrent Metastatic Head and Neck Cancer	9
Minimal Residual Disease in Mantle Cell Lymphoma	9
Developing Precision Medicine for Bladder Cancer	9
Immunotherapy for Head and Neck Cancer	8
Systemic Amyloidosis Due to Clonal Plasma Cell Diseases	8
Cancer of the Paranasal Sinuses	8
Gene Therapy and Gene Editing for β-Thalassemia	8
Contemporary and Emerging Approaches to Bladder-Preserving Trimodality Therapy for Muscle-Invasive Bladder Cancer	8
Monoclonal Antibody Therapies in Systemic Light-Chain Amyloidosis	8
Systemic Amyloidosis due to Low-Grade Lymphoma	8
Salivary Gland Cancers	8
Chemotherapy Options for Blastic Plasmacytoid Dendritic Cell Neoplasm	8
Should Undetectable Minimal Residual Disease Be the Goal of Chronic Lymphocytic Leukemia Therapy?	8
The Process of Amyloid Formation due to Monoclonal Immunoglobulins	8
Factor XIII Deficiency	8
Hemophilia A (Factor VIII Deficiency)	7
Updates on the Diagnosis and Management of Cold Autoimmune Hemolytic Anemia	7
Structural Racism and Impact on Sickle Cell Disease	7
Cancer of the Larynx and Hypopharynx	7
Thrombotic, Vascular, and Bleeding Complications of the Myeloproliferative Neoplasms	7
Neurocognition and Health-Related Quality of Life Among Patients with Brain Tumors	7
Stem Cell Mobilization and Autologous Transplant for Immunoglobulin Light-Chain Amyloidosis	7
Go the Distance	7
Neurofibromatoses	7
Application of Stem Cell Therapy in Myelofibrosis	6
Hemophilia B (Factor IX Deficiency)	6

Potential Relevance of B-cell Maturation Pathways in Defining the Cell(s) of Origin for Chronic Lymphocytic Leukemia	6
Do Recent Randomized Trial Results Influence which Patients with Myelodysplastic Syndromes Receive Iron Chelation?	6
A Curative DNA Code for Hematopoietic Defects	6
Isocitrate Dehydrogenase Mutant Grade II and III Glial Neoplasms	6
Renal Cell Carcinoma of Variant Histology	6
The Clinical Phenotypes of Alpha Thalassemia	6
The Evolving Use of Phosphatidylinositol 3-Kinase Inhibitors for the Treatment of Chronic Lymphocytic Leukemia	6
Adult Evans' Syndrome	6
Real World Outcomes of Patients with Bladder Cancer	6
Allogeneic Transplantation and Chimeric Antigen Receptor-Engineered T-Cell Therapy for Relapsed or Refractory Mantle Cell Lymphoma	6
Cell Cycle Dysregulation in Mantle Cell Lymphoma	6
Chimeric Antigen Receptor T-cell Therapy	6
Preclinical Models for Bladder Cancer Research	6
Management of Rectal Cancer	6
Autoimmune Hemolytic Anemia: Diagnosis and Differential Diagnosis	6
Robotic and Endoscopic Approaches to Head and Neck Surgery	5
Evolution of Gene Therapy, Historical Perspective	5
Gene Therapy for Inborn Errors of Immunity	5
Watch and Wait in Mantle Cell Lymphoma	5
Advanced Melanoma	5
Update on Radiation Therapy for Central Nervous System Tumors	5
Liver and Gastrointestinal Involvement	5
Immune Therapy for Chronic Lymphocytic Leukemia	5
Ex Vivo and In Vivo Gene Therapy for Mucopolysaccharidoses: State of the Art	5
Is There a Role for Immunotherapy in Central Nervous System Cancers?	5
Systemic Amyloidosis Caused by Monoclonal Immunoglobulins	5
Application of Single-Cell Approaches to Study Myeloproliferative Neoplasm Biology	5
Nonoperative Management for Rectal Cancer	5
Combinatorial Approaches to the Treatment of Advanced Melanoma	5
Convergence of Precision Oncology and Liquid Biopsy in Non-Small Cell Lung Cancer	5
The Biological Basis of Histologic Transformation	5
Disparities and Inequities Among Patients with Central Nervous System Tumor	5
Blastic Plasmacytoid Dendritic Cell Neoplasm	4
Surgical Management of the Axilla for Breast Cancer	4
Quality of Life in Sickle Cell Disease	4
Molecular Basis and Genetic Modifiers of Thalassemia	4
Current Therapy for Metastatic Urothelial Carcinoma	4
Immunotherapy-associated Autoimmune Hemolytic Anemia	4
Hematopoietic Stem Cell Transplantation in Thalassemia	4
Surgery for Bladder and Upper Tract Urothelial Cancer	4
Immune Checkpoint Therapies for Melanoma	4
Accelerated and Blast Phase Myeloproliferative Neoplasms	4
The Clinical Utility of ESR1 Mutations in Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer	4
Treatment of Histologic Transformation	4
Epigenetic Dysregulation of Myeloproliferative Neoplasms	4
Imaging Advances for Central Nervous System Tumors	4
Cytogenetics of Blastic Plasmacytoid Dendritic Cell Neoplasm	4
Emerging Therapies in β-Thalassemia	4
The Evolving Landscape of Drug Therapies for Sickle Cell Disease	4
Approach to the Initial Treatment of Older Patients with Mantle Cell Lymphoma	4
Supportive Care for Patients with Systemic Light Chain Amyloidosis	4
Systemic Amyloidosis due to Monoclonal Immunoglobulins	4
State of Melanoma	4
Role of Ovarian Suppression in Early Premenopausal Breast Cancer	4
Future Perspectives	4
Emerging Targeted Therapy for Bladder Cancer	4
Red Cell Antigens and Antibodies	4
Quality of Life in Myeloproliferative Neoplasms	4
Novel Prognostic Models for Myelodysplastic Syndromes	4
Fetal Hemoglobin Regulation in Beta-Thalassemia	4
Genetic Modifiers of Sickle Cell Disease	4
Molecular Biology of Bladder Cancer	4
Clinical and Biological Prognostic Factors in Follicular Lymphoma	3
Economics of Sickle Cell Disease and Evidence to Support Comprehensive Care	3
Extracutaneous Melanoma	3
Genetics of Pancreatic Neuroendocrine Tumors	3
Immunotherapy and Immunomodulation in Myeloproliferative Neoplasms	3
Biology and Treatment of HER2-Low Breast Cancer	3
Bruton Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia	3
Clinical Challenges with Iron Chelation in Beta Thalassemia	3
Liver and Gastrointestinal Involvement	3
Cancer of the Oropharynx and the Association with Human Papillomavirus	3
Chronic Pain	3
Can Immunocompetence Be Restored in Chronic Lymphocytic Leukemia?	3
The Significance of B-cell Receptor Stereotypy in Chronic Lymphocytic Leukemia	3
Management of Brain Metastases in Metastatic Renal Cell Carcinoma	3
Biology and Treatment of Meningiomas	3
The Gut Microbiome in Colorectal Cancer	3
Local Therapies in Advanced Colorectal Cancer	3
Updates in the Management of Warm Autoimmune Hemolytic Anemia	3

Treatment of Acquired Sideroblastic Anemias	3
Advancing Effective Clinical Trial Designs for Myelofibrosis	2
Blastic Plasmacytoid Dendritic Cell Neoplasm	2
Pathogenic Mechanisms in Thalassemia I	2
Role of Immunotherapy in Early- and Late-Stage Triple-Negative Breast Cancer	2
Insights into Renal Cell Carcinoma with Novel Imaging Approaches	2
Is Limited-Stage Mantle Cell Lymphoma Curable and How Is It Best Managed?	2
Central Nervous System Complications Among Oncology Patients	2
Management of Peritoneal Disease in Colorectal Cancer	2
Decision-Making Regarding Perioperative Therapy in Individuals with Localized Pancreatic Adenocarcinoma	2
What Is Responsible for Heterogeneity in Mantle Cell Lymphoma Biology and Outcomes?	2
The Impact of AL Amyloidosis	2
Breast Cancer and Lifestyle Factors	2
Disparities in Breast Cancer Outcomes and How to Resolve Them	2
Chimeric Antigen Receptor T Cells in Acute Myeloid Leukemia	2
Current Perioperative Therapy for Muscle Invasive Bladder Cancer	2
Immunomodulatory Agents in Follicular Lymphoma	2
Antibody Therapy Maintenance in Follicular Lymphoma	2
Early Progression of Follicular Lymphoma	2
First-Line Therapy for Chronic Lymphocytic Leukemia	2
Current and Emerging Role of Antibody–Drug Conjugates in HER2-Negative Breast Cancer	2
BTK Inhibitors in the Frontline Management of Waldenström Macroglobulinemia	2
The Cardiopulmonary Complications of Sickle Cell Disease	2
Radiologic Evaluation of the Head and Neck Cancer Patient	2
Prognostic and Predictive Implications of Cytogenetics and Genomics	2
Radiotherapy for Pancreatic Adenocarcinoma	2
Novel Agents in Waldenström Macroglobulinemia	2
The Need for Translational Epidemiology in Beta Thalassemia Syndromes	2
Isocitrate Dehydrogenase Wild-type Glial Tumors, Including Glioblastoma	2
Allogeneic Transplant and Gene Therapy	2
Pathogenic Mechanisms in Thalassemia II	2
Solid Organ Transplantation	2
Where Does Morphology Fit in Myelodysplastic Syndrome Diagnosis in the Era of Molecular Testing?	2
Adjuvant Systemic Therapy for Postmenopausal, Hormone Receptor-Positive Early Breast Cancer	2
Initial Treatment of Early Stage and Low Tumor Burden Follicular Lymphoma	2
Initial and Consolidation Therapy for Younger Patients with Mantle Cell Lymphoma	2
Adjuvant Therapy of Melanoma	2
The Role of Chimeric Antigen Receptor T-Cell Therapy in the Era of Bispecific Antibodies	2
Sickle Cell Disease Pathophysiology and Related Molecular and Biophysical Biomarkers	2
The Interplay Among Pancreatic Cancer, Cachexia, Body Composition, and Diabetes	2
Hereditary Renal Cell Carcinoma Syndromes	2
Adeno-Associated Virus Vector Design–Moving the Adeno-Associated Virus to a Bioengineered Therapeutic Nanoparticle	2
Cytotoxic Chemotherapy in Advanced Pancreatic Cancer	2
Inherited Platelet Disorders	2
Evidence-Based Guidance for Breast Cancer Survivorship	2
Mechanisms of Resistance to Chimeric Antigen Receptor T Cell Therapy	2
Complications of Autoimmune Hemolytic Anemia	2
von-Hippel Lindau and Hypoxia-Inducible Factor at the Center of Renal Cell Carcinoma Biology	2
The Evolving Role for Systemic Therapy in Resectable Non-small Cell Lung Cancer	2
Renal Involvement in Systemic Amyloidosis Caused by Monoclonal Immunoglobulins	2
Breast Cancer Pathology in the Era of Genomics	2
First-Line Treatment for Intermediate and Poor Risk Advanced or Metastatic Clear Cell Renal Cell Carcinoma	1
Thalassemia	1
Toward a Cure for Follicular Lymphoma	1
Fertility and Pregnancy in Women with Transfusion-Dependent Thalassemia	1
New Developments in the Understanding and Treatment of Autoimmune Hemolytic Anemia: Traditional and Novel Tests	1
Laboratory Methods in the Assessment of Hereditary Hemostatic Disorders	1
Understanding Health-Related Quality of Life in Patients with Mantle Cell Lymphoma	1
The Development of Neuroimaging Biomarkers for Cognitive Decline in Sickle Cell Disease	1
New Therapies on the Horizon	1
Frontline Management of Waldenström Macroglobulinemia with Chemoimmunotherapy	1
Treatment of Chronic Lymphocytic Leukemia After Discontinuation of Bruton’s Tyrosine Kinase Inhibitors	1
Renal Cell Cancer	1
Immunotherapy for Colorectal Cancer	1
Palliative and Supportive Care for Individuals with Pancreatic Adenocarcinoma	1
Genes as Medicine	1
Advances in Surgical Techniques for Lung Cancer	1
Proteasome Inhibitor-Based Regimens in the Frontline Management of Waldenström Macroglobulinemia	1
Role of Surgery in Metastatic Renal Cell Carcinoma	1
Important Pathologic Considerations for Establishing the Diagnosis of Myelofibrosis	1
Genotyping and the Future of Transfusion in Sickle Cell Disease	1
Peripheral Nervous System Involvement	1
The Management of Relapsed or Refractory Waldenström’s Macroglobulinemia	1
More Drugs Versus More Data: The Tug of War on Cancer in Low- and Middle-Income Countries	1
Nonsurgical Therapy for Early-Stage Lung Cancer	1
New Insights into Adjuvant Therapy for Localized Colon Cancer	1
Evaluation and Management of Disease Transformation in Waldenström Macroglobulinemia	1
Genomics of Resistance to Targeted Therapies	1
The Current State of Chimeric Antigen Receptor T Cell Therapy for B Lymphoblastic Leukemia	1
Cellular Therapy in Follicular Lymphoma	1
What Causes Bruton Tyrosine Kinase Inhibitor Resistance in Mantle Cell Lymphoma and How Should We Treat Such Patients?	1
Gene-Based Natural Killer Cell Therapies for the Treatment of Pediatric Hematologic Malignancies	1
The Ongoing Unmet Needs in Chronic Lymphocytic Leukemia	1
Central Nervous System Tumor Classification	1
Sickle Cell Disease and the Kidney	1
Phosphatidylinositol-3-Kinase Inhibition in Follicular Lymphoma	1
Surgical Management of Localized Disease and Small Renal Masses	1
PARPis and Other Novel, Targeted Therapeutics in Pancreatic Adenocarcinoma	1
Chimeric Antigen Receptor T-Cells in Indolent Lymphoma, Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia	1
Unmet Need in Essential Thrombocythemia and Polycythemia Vera	1
Approach to the Patient with Bleeding	1
Blastic Plasmacytoid Dendritic Cell Neoplasm in 2020 and Beyond	1
Evaluation and Management of Bing–Neel Syndrome	1
The Evolving Role of Neurosurgical Intervention for Central Nervous System Tumors	1
State of the Art of Pathologic and Molecular Testing	1